Navigation Links
International experts to explore new 'wonderdrug' at conference

A gas associated with the smell of rotten of eggs is now being proven to have widespread health benefits. Hydrogen Sulfide (H2S) is widely known as a poisonous and corrosive substance, but now a mounting body of evidence suggests it could be used in a wide range of treatments for some of the biggest health problems of our time. A conference hosted by the University of Exeter will bring together world-leading scientists to explore the emerging possibilities.

The conference will take place from September 8 to 11, and will discuss new research which shows that H2S can play a role in a diverse range of functions. They include reducing joint swelling, treating cancer, preeclampsia, neurodegenerative disease, cardiovascular disease and diabetes and even helping plants grow in the dark.

On Sunday September 8 Professor Hideo Kimura will give an overview in the opening plenary entitled "Physiological Function of Hydrogen Sulfide and Beyond". The talk will take place at the Forum on the University's Streatham Campus. It starts at 6pm and is free to attend.

Conference organiser Professor Matt Whiteman, of the University of Exeter Medical School, is a world-leader in research on H2S. He said: Scientists began to take a real interest in H2S when it was discovered that the body naturally produces small quantities of this seemingly dangerous substance. Since then researches from around the world have been intrigued by the potential benefits. It very much appears from the rapidly growing body of scientific and medical literature that H2S is emerging as something of a potential wonderdrug and could in fact hold the key to solving some of our most widespread health problems such as diabetes, high blood pressure, heart attacks and arthritis. The key to unlocking these benefits is using it in the right way."


Contact: Louise Vennells
University of Exeter

Page: 1

Related biology news :

1. Ultracold matter technology from CU and SRI International licensed to Boulders ColdQuanta
2. International Polar Year conference: From knowledge to action
3. Large international study finds memory in adults impacted by versions of 4 genes
4. International team uncovers new genes that shape brain size, intelligence
5. Southampton researchers lead 2 international projects to help people out of poverty
6. UCSD researchers: Where international climate policy has failed, grassroots efforts can succeed
7. Washington University receives $8 million to lead international childhood malnutrition effort
8. Early Bird Discounts Available on International Healthcare and Biotechnology Conferences, Save Up To $600 with Global Information
9. New HealthFocus® International Study Reveals Five Very Different Weight Management Consumers
10. OU scientists and international team deciper the genetic code of the tomato
11. Digicel Launches Worlds First Biometric Identification System For International Money Transfers
Post Your Comments:
(Date:11/18/2015)... New York , November 18, 2015 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2021. According to the ... in 2014 and is anticipated to reach US$29.1 bn ... to 2021. North America ...
(Date:11/17/2015)... 17, 2015 Paris ... --> Paris , qui s,est ... DERMALOG, le leader de l,innovation biométrique, a inventé le ... et empreintes sur la même surface de balayage. Jusqu,ici, ... l,autre pour les empreintes digitales. Désormais, un seul scanner ...
(Date:11/17/2015)... Mass. , Nov. 17, 2015 Pressure ... leader in the development and sale of broadly enabling, ... worldwide life sciences industry, today announced it has received ... its $5 million Private Placement (the "Offering"), increasing the ... $4,025,000.  One or more additional closings are expected in ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... uBiome, were featured on AngelList early in their initial angel funding process. Now, ... syndicate for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
Breaking Biology Technology: